$70.33
-0.65-0.92%
al cierre: -
$70.33
0.000.00%
After hour: 4:00 PM EDT
Comments
Loading...
Orientación y previsiones
Corcept Therapeutics emite una orientación sobre las ganancias por acción y los ingresos futuros, lo que ofrece a los inversores una idea de cuánto espera ganar la empresa en los próximos períodos.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
07/31/2025 | CORT | Corcept Therapeutics | FY | 2025 | — | — | — | $850.00M | $900.00M | $899.05M | |
05/05/2025 | CORT | Corcept Therapeutics | FY | 2025 | — | — | — | $900.00M | $950.00M | $899.05M | |
02/26/2025 | CORT | Corcept Therapeutics | FY | 2025 | — | — | — | $900.00M | $950.00M | $899.05M | |
10/30/2024 | CORT | Corcept Therapeutics | FY | 2024 | — | — | — | $675.00M | $700.00M | $692.67M | |
07/29/2024 | CORT | Corcept Therapeutics | FY | 2024 | — | — | — | $640.00M | $670.00M | $692.67M | |
05/01/2024 | CORT | Corcept Therapeutics | FY | 2024 | — | — | — | $620.00M | $650.00M | $692.67M | |
02/15/2024 | CORT | Corcept Therapeutics | FY | 2024 | — | — | — | $600.00M | $630.00M | $531.57M | |
01/08/2024 | CORT | Corcept Therapeutics | Q4 | 2023 | — | — | — | $135.40M | $135.40M | $127.85M | |
01/08/2024 | CORT | Corcept Therapeutics | FY | 2023 | — | — | — | $482.40M | $482.40M | $474.82M | |
01/08/2024 | CORT | Corcept Therapeutics | FY | 2024 | — | — | — | $600.00M | $630.00M | $513.85M | |
11/01/2023 | CORT | Corcept Therapeutics | FY | 2023 | — | — | — | $470.00M | $480.00M | $465.62M | |
08/02/2023 | CORT | Corcept Therapeutics | FY | 2023 | — | — | — | $455.00M | $470.00M | $443.89M | |
05/03/2023 | CORT | Corcept Therapeutics | FY | 2023 | — | — | — | $435.00M | $455.00M | $435.73M | |
02/28/2023 | CORT | Corcept Therapeutics | FY | 2023 | — | — | — | $430.00M | $450.00M | $434.79M | |
11/03/2022 | CORT | Corcept Therapeutics | FY | 2022 | — | — | — | $400.00M | $410.00M | $416.67M | |
08/03/2022 | CORT | Corcept Therapeutics | FY | 2022 | — | — | — | $400.00M | $430.00M | $414.43M | |
05/05/2022 | CORT | Corcept Therapeutics | FY | 2022 | — | — | — | $400.00M | $430.00M | $413.85M | |
02/15/2022 | CORT | Corcept Therapeutics | FY | 2022 | — | — | — | $400.00M | $430.00M | $413.19M | |
11/03/2021 | CORT | Corcept Therapeutics | FY | 2021 | — | — | — | $365.00M | $375.00M | $371.75M | |
07/29/2021 | CORT | Corcept Therapeutics | FY | 2021 | — | — | — | $355.00M | $385.00M | $370.69M | |
05/06/2021 | CORT | Corcept Therapeutics | FY | 2021 | — | — | — | $355.00M | $385.00M | $396.20M | |
02/23/2021 | CORT | Corcept Therapeutics | FY | 2021 | — | — | — | $375.00M | $405.00M | $398.27M | |
02/08/2021 | CORT | Corcept Therapeutics | FY | 2021 | — | — | — | $375.00M | $405.00M | $403.17M | |
02/08/2021 | CORT | Corcept Therapeutics | FY | 2020 | $0.85 | $0.85 | $0.80 | $353.90M | $353.90M | $358.48M | |
02/08/2021 | CORT | Corcept Therapeutics | Q4 | 2020 | $0.20 | $0.20 | $0.20 | $85.70M | $85.70M | $96.17M |
PREGUNTAS FRECUENTES
¿Cuál es la orientación más reciente de Corcept Therapeutics (CORT)?
La orientación más reciente para Corcept Therapeutics (CORT) se informó el febrero 8, 2021 para el año completo 2020. La empresa proporcionó una guía de ganancias por acción en el rango de $0.85 a $0.85, en comparación con el EPS estimado de $0.80. Además, Corcept Therapeutics pronosticó ingresos entre $0.35B y $0.35B para el trimestre.
Explora orientación y previsión sobre todos los valores.